DHCR24 and metastatic malignant neoplasm in the lymph nodes: Dai et al. found that DHCR24 expression levels were significantly elevated in EC patients, and that upregulated DHCR24 was associated with advanced EC, lymph node metastasis, and decreased overall survival [91].